Introduction: The evaluation of the patients' perspective of psychiatric admission is useful to define what is the therapeutic milieu and important to improve treatment quality.
Aim: This study aimed to explore the patients' perspective of psychiatric admission to a residential unit for intensive rehabilitation treatment.
Methods: A questionnaire, assessing the patients' experiences of psychiatric admission developed from previous studies, has been administered to a series of inpatients at the rehabilitation unit "La Luna", University of Ferrara, Department of Mental Health.
Results: 40 patients (20 depressed and 20 schizophrenic) participated in the study. Some dimensions, such as protection from the external world (85% of depressed and 65% of schizophrenic) and opportunity to recover their own existence (75% of depressed and 65% of schizophrenic) emerged as the main experiences. The subjects (85% of depressed and 70% of schizophrenic) also reported to have a good relationship (caring and empathic) with the staff and other patients and to perceive a sense of universality, without the anxiety of living with other severe patients (65% of depressed and 55% of schizophrenic). Schizophrenic patients felt to be limited by the experience of admission more than the depressed (20% of depressed and 60% of schizophrenic, p<0.05). The most influential factor of negative or positive experience was the quality of relationship with the staff and other patients.
Conclusions: This study outlines the importance of therapeutic relationship in patients' perspective of psychiatric admission and suggests broader attention to human quality on therapeutic approach.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Consumption patterns before and during the COVID-19 pandemic among patients admitted to inpatient drug detoxification treatment: Results of two cross-sectional surveys from 2018 and 2021.
Front Psychiatry
December 2024
LVR-University Hospital Essen, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Background: The lockdown measures during the SARS-CoV-2 pandemic could have influenced drug consumption patterns of persons with drug use disorder, especially due to a reduced availability of drugs, an increased consumption of sedating substances as a coping strategy, or a shift to novel psychotropic substances (NPS) associated with an increased drug buying in the internet. In this study, the consumption patterns of people mainly with opioid use disorder entering inpatient drug detoxification treatment were investigated in the same hospitals with the same methods before and during the pandemic.
Methods: At admission, patients were interviewed regarding their consumption patterns using the EuropASI questionnaire.
Hyponatremia incidence after subarachnoid hemorrhage and association with outcomes: systematic review and meta-analysis.
World Neurosurg
December 2024
Department of Neurosurgery, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK.
Objective: Hyponatremia after aneurysmal subarachnoid hemorrhage (aSAH) is common, however the incidence, and association with vasospasm, morbidity, and mortality, has yet to be defined. We aimed to identify incidence of hyponatremia after aSAH, and quantify its association with measurable outcomes.
Methods: A PRISMA-compliant systematic review and meta-analysis was conducted (PROSPERO ID CRD42022363472).
Ofatumumab treatment in new-onset narcolepsy type 1 following SARS-CoV-2 infection.
Ann Clin Transl Neurol
December 2024
Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Objectives: To explore the efficacy of ofatumumab in new onset narcolepsy type 1 following SARS-CoV-2 infection.
Methods: We present a 9-year-old girl who experienced new onset narcolepsy type 1 following SARS-CoV-2 infection. Polysomnography (PSG) followed by a daytime multiple sleep latency test (MSLT) was under taken after admission.
Prescription psychostimulant use, admissions and treatment initiation and retention in pregnant people with opioid use disorder.
Nat Ment Health
July 2024
Department of Family/Community Medicine and Health and Outcomes Research, Saint Louis University School of Medicine, St. Louis, MO, USA.
While attention deficit hyperactivity disorder is common among people with addiction, the risks and benefits of attention deficit hyperactivity disorder medication in pregnant people with opioid use disorder are poorly understood. Here, using US multistate administrative data, we examined 3,247 pregnant people initiating opioid use disorder treatment, of whom 5% received psychostimulants. Compared to peers not receiving psychostimulants, the psychostimulant cohort had greater buprenorphine (adjusted relative risk 1.
View Article and Find Full Text PDFChallenges of Dementia Care in a Regional Australian Hospital: Exploring Interventions to Minimise Length of Stay for Dementia Patients.
Aust J Rural Health
February 2025
Mackay Hospital and Health Service, Mackay, Queensland, Australia.
Objective: There are significant difficulties associated with the management of dementia patients in hospitals, leading to adverse patient outcomes, prolonged length of stay (LOS), strain on resources and high readmission rates. This study aimed to investigate these factors in the context of a regional hospital.
Design: This study retrospectively reviewed all dementia admissions in a publicly funded Australian regional hospital from January 2022 to December 2022.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!